Hyperimmune horse serum from a single animal (horse 46) immunized with group B (strain B-11) meningococcal vaccine provides a standardized, readily available diagnostic reagent used in primary isolation medium and for serogrouping of meningococci. Identification of the heavy-chain isotypes of specific anticapsular polysaccharide and anti-lipopolysaccharide isolated from horse 46 serum revealed a differential distribution in the occurrence of immunoglobulin classes. Meningococcal anticapsular antibodies of horse 46 serum were restricted predominately to the immunoglobulin M (IgM) class, with only trace amounts of IgGa present, whereas anti-lipopolysaccharide concomitantly produced showed a heterogeneity in its heavy-chain isotypes, consisting of IgM, IgGa, IgGb, moderate amounts of IgB, and a small amount of IgA.
Specific hyperimmune horse serum from a single animal (horse 46), immunized with group B (strain B-11) meningococcal vaccine has provided a useful reagent extensively used in primary isolation medium, large-scale serogrouping, and immunochemical studies on capsular polysaccharide (5, 7, 15, 19, 21) . Because of its continued wide use as a readily available, standardized, diagnostic reagent, the heavy-chain isotypes of anticapsular and anti-lipopolysaccharide (LPS) antibodies present in horse 46 group B meningococcal antiserum were specifically identified and are the subject of this report.
MATERIALS AND METHODS
Horse anti-meningococcal serum. Horse group B anti-meningococcal serum was obtained from a single animal (horse 46) immunized with freshly prepared, Formalin-treated suspensions of group B (strain B-11) meningococci, as described by Alexander et al. (1) .
Anti-equine immunoglobulin reagents. The preparation of monospecific rabbit anti-heavy-chain reagents specific for equine IgGa, IgGb, lgGc, IgB, IgG(T), IgA, and IgM have been previously described (2, 9) .
Antigens. The preparation and characterization of purified Escherichia coli Kl and E. coli Kl (O-acetyl positive) variant polysaccharides have been described by Orskov et al. (15) . The capsular polysaccharides of E. coli Kl and group B meningococci are immunologically indistinguishable, linear homopolymers of (2 --8)-a-linked N-acetyl neuraminic acid (3, 8, 11, 13, 15, 17) . Purified meningococcal lipopolysaccharide (M986) was provided by C. E. Frasch (6) .
Gel filtration. Gel filtration was carried out on a column (75 by 2.5 cm) of Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Piscataway, N.J.) equilibrated with 0.01 M phosphate buffer (pH 7.4), containing 0.85 sodium chloride and 0.025% sodium azide. Serum samples (2.5 ml), saturated with sucrose, were applied to the bottom of the column, and filtration was done by an ascending flow of phosphate-buffered saline used as eluent. Fractions (3.5 ml/tube) were collected, and the UV absorption at 280 nm was determined. Immunoglobulins present in each 3.5-ml fraction were identified by immunodiffusion analysis, employing monospecific anti-horse immunoglobulin heavy-chain reagents. Anti-meningococcal antibody present in each fraction was detected by diffusion in agar against E. coli Kl capsular polysaccharide and meningococcal LPS. Fractions containing macroglobulins eluted in the void volume (peak 1) or 7 to 11 S globulins (peak 2) obtained from four separate 2.5-ml samples of horse 46 serum were pooled, concentrated by ultrafiltration to approximately 2 ml, and reapplied to the same column. Individual fractions obtained from peaks 1 and 2 after a repeated gel filtration were examined by immunodiffusion and countercurrent immunoelectrophoresis for heavy-chain isotypes and reactivity with antigen.
Immunodiffusion and immunoelectrophoresis. Twodimensional gel diffusion was carried out in 1% agar in 0.02 M phosphate-buffered saline (pH 7.2) . Reactants (about 10 ,ul) were placed into 3-mm wells separated by a 3-mm distance. Each 3.5-ml fraction obtained from gel filtration of horse 46 serum was diffused against solutions of E. coli Kl polysaccharide (1 mg/ ml), meningococcal LPS (200 jig/ml), and rabbit antiequine heavy-chain reagent.
Preparations of specifically isolated horse 46 antibody containing 1.0, 0.50, 0.25, 0.10, and 0.050 mg of antibody per ml were examined by diffusion against monospecific rabbit anti-equine heavy-chain reagents to identify isotypes present. Immunoelectrophoresis was carried out in 1% Noble agar (Difco Laboratories, Detroit, Mich.) in 0.035 M barbital buffer (pH 8.6). Countercurrent immunoelectrophoresis was carried out essentially as described by Semjen et al. (20) .
Quantitative precipitin determinations. Preliminary quantitative precipitin determinations done by adding increasing amounts of E. coli Kl or Kl (O-acetyl positive) polysaccharide to 250 .l of horse 46 serum showed that 30 to 100 p.g of polysaccharide was required to precipitate a maximum of 52 ,ug of antibody nitrogen, equivalent to 359 ,ug of IgM antibody protein. Similarly, 50 to 200 p.g of meningococcal LPS maximally precipitated 22 p.g of antibody nitrogen from 500 ,ul of serum. Prior absorption of horse 46 serum with Kl capsular polysaccharide showed no effect on the quantitative recovery of anti-LPS. The total volume of all reaction mixtures was adjusted to 1.25 ml with saline, and tubes were kept in an ice bath at 0°C for 7 days. Nitrogen was estimated by microKjeldahl analysis, as described by Kabat (10) . A nitrogen content for IgM of 14.5% was used to convert nitrogen to antibody protein (12) .
Specific isolation of anti-meningococcal immunoglobulins. Anticapsular antibodies were precipitated from 2.5 ml of horse 46 serum by the addition of 250 ,u1 of antigen solution containing 350 ,ug of Kl capsular polysaccharide. The reaction mixture was kept at 0°C for 7 days. The specific antigen-antibody precipitate was isolated by centrifugation, then washed repeatedly with ice-cold saline until the optical density at 280 nm of the wash was 0.025. The washed specific precipitate was suspended in 2.0 ml of 15% sodium chloride and kept for 1 h at 37°C, with gentle agitation. Antibody solubilized by strong salt was separated from salt-insoluble complex by centrifugation. The salt-insoluble residue was dissolved in 5 mM NaOH. Solutions of strong salt or alkali-solubilized complex were examined by immunodiffusion to identify the equine heavy-chain isotypes present.
Anti-meningococcal globulins were also precipitated from separate 2.5-ml samples of horse 46 serum by addition of the optimal amounts of Kl capsular polysaccharide or meningococcal LPS required for maximum antibody precipitation. Immunoprecipitates were washed four times with 3-ml portions of ice-cold saline. The entire precipitate was dissolved in 25 ,ul of 0.5 N NaOH, then diluted with 15% sodium chloride to provide solutions containing 1.0 or 0.50 mg of antibody per ml. A specific extinction coefficient E1% I cm. 280 nm = 13.5 was used to estimate the protein content of solutions of isolated antibody (12) . Solutions of alkalisolubilized complex were examined by immunodiffusion to identify the heavy-chain isotypes present.
RESULTS
Gel filtration. The elution profile of anti-meningococcal horse 46 serum proteins from Sephadex G-200 is shown in Fig. 1 Fig. 2 .
Anti-meningococcal antibodies precipitable by E. coli Kl capsular polysaccharide or meningococcal LPS were confined to fractions comprising pool 1 (Fig. 1) . Anti-meningococcal precipitins were not detected by immunodiffusion or countercurrent immunoelectrophoresis among immunoglobulins present in each individual 3.5-ml fraction of pool 2. When fractions comprising each respective pool were combined, concentrated, and reapplied to Sephadex G-200 (Fig. 1) , anticapsular carbohydrate and anti-LPS were again confined to the IgM-enriched fractions of pool 1. The presence of antibody in 3.5-ml fractions of pool 2 was not detectable by immunodiffusion. However, when pool 2 fractions were combined, concentrated 125-fold by ultrafiltration, and diffused against LPS, the occurrence of anti-LPS in pool 2 could be demonstrated by immunodiffusion.
Identification of heavy-chain isotypes of immunoprecipitated antibody. When a washed, specific immunoprecipitate formed by adding an equivalent amount of E. coli Kl capsular polysaccharide to 2.5 ml of horse 46 serum was extracted with 15% NaCl, 70% of the total anticapsular antibody precipitated could be readily solubilized, whereas 30% of the antibody remained insoluble and required dilute alkali for solubilization ( Table 1) . Diffusion of salt-extract- e Barely detectable band when tested at 500. 250. 100. and 50 ,ug of antibody per ml.
ed and alkali-solubilized fractions of anticapsular antibody in agar against monospecific antiequine heavy-chain isotype reagents showed IgM to be the predominant immunoglobulin present (Table 1) . When examined at high concentration (1 mg/ml), only a trace of IgGa was detectable in both salt-extracted and alkali-solubilized fractions of specifically isolated anticapsular antibody. Similarly, immunodiffusion analysis of 3.14 mg of antibody precipitated by Kl capsular polysaccharide and then solubilized directly in dilute alkali showed the bulk of the anticapsular antibody to be of the IgM class with only trace amounts of IgGa, present (Fig. 3A and Table 1 ).
Since only 13% of the total antibody precipitated by meningococcal LPS could be solubilized by strong salt, 0.77 mg of anti-LPS precipitated at equivalence with LPS was directly solubilized in dilute alkali and examined by agar diffusion (Table 1) . Immunodiffusion analysis of isolated, solubilized anti-LPS (Fig. 3B) secondary-type, IgG-producing B cells (14) . The meningococcal anticapsular carbohydrate response of horse 46 showed a restricted occurrence of heavy-chain isotypes, confined predominately to the IgM isotype, and thus resembled the response described for S. faecalis vaccines. In contrast to the IgM-restricted anticapsular polysaccharide response, anti-LPS concomitantly produced by horse 46 showed a marked heterogeneity in the occurrence of heavy-chain isotypes. The basis for this heavychain isotype diversity is not known, but it may perhaps be related to the ability of LPS and associated proteins to function as a polyclonal B cell activator.
